Exact Mass: 597.2785

Exact Mass Matches: 597.2785

Found 28 metabolites which its exact mass value is equals to given mass value 597.2785, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cadabicine glucoside

Cadabicine glucoside

C31H39N3O9 (597.2686)


   

Capparispine glucoside

Capparispine glucoside

C31H39N3O9 (597.2686)


   

rubellidin 1|Val-Asp-Phe-Phe-Ala(OH)

rubellidin 1|Val-Asp-Phe-Phe-Ala(OH)

C30H39N5O8 (597.2798)


   

2-N-Acetylbutirosin A

2-N-Acetylbutirosin A

C23H43N5O13 (597.2857)


   

3,5-bis(3-methyl-2-butenyl)-4-O-[beta-D-glucopyranosyl-(1?2)-beta-D-glucopyranosyl]benzamide

3,5-bis(3-methyl-2-butenyl)-4-O-[beta-D-glucopyranosyl-(1?2)-beta-D-glucopyranosyl]benzamide

C29H43NO12 (597.2785)


   

3,5-bis(3-methyl-2-butenyl)-4-O-[beta-D-glucopyranosyl-(1?4)-beta-D-glucopyranosyl]benzamide

3,5-bis(3-methyl-2-butenyl)-4-O-[beta-D-glucopyranosyl-(1?4)-beta-D-glucopyranosyl]benzamide

C29H43NO12 (597.2785)


   
   

TOG10

12-Oxo-10-(S-glutathionyl)-5Z,8Z,14Z-eicosatrienoic acid

C28H43N3O9S (597.272)


   

FOG7

5-oxo-7-(S-glutathionyl)-8Z,11Z,14Z-eicosatrienoic acid

C28H43N3O9S (597.272)


   

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C33H38F3N3O4 (597.2814)


   

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C33H38F3N3O4 (597.2814)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C33H38F3N3O4 (597.2814)


   

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C33H38F3N3O4 (597.2814)


   

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C33H38F3N3O4 (597.2814)


   

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C33H38F3N3O4 (597.2814)


   

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C33H38F3N3O4 (597.2814)


   

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C33H38F3N3O4 (597.2814)


   
   

12-ethyl-8-isobutyl-3-vinylbacteriochlorophyllide d(1-)

12-ethyl-8-isobutyl-3-vinylbacteriochlorophyllide d(1-)

C36H37MgN4O3 (597.2716)


A cyclic tetrapyrrole anion that is the conjugate base of 12-ethyl-8-isobutyl-3-vinylbacteriochlorophyllide d, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   

ST 21:3;O7;HexNAc

ST 21:3;O7;HexNAc

C29H43NO12 (597.2785)


   

N-terminally acetylated Leu-enkephalin

N-terminally acetylated Leu-enkephalin

C30H39N5O8 (597.2798)


N-terminally acetylated Leu-enkephalin is the N-terminally acetylated form of Leu-enkephalin. Leu-enkephalin is a five amino acid endogenous peptide that acts as an agonist at opioid receptors.

   

(1r,3s,5r,7r,8r,9r,10r,15r)-15-[(3r)-2,2-dimethyl-5-oxooxolan-3-yl]-7-[1-(3-hydrazinylpropanoyl)-2-oxo-5h-pyrrol-3-yl]-8,15-dimethyl-2-methylidene-12-oxo-4,11-dioxatetracyclo[8.5.0.0³,⁵.0³,⁸]pentadec-13-en-9-yl acetate

(1r,3s,5r,7r,8r,9r,10r,15r)-15-[(3r)-2,2-dimethyl-5-oxooxolan-3-yl]-7-[1-(3-hydrazinylpropanoyl)-2-oxo-5h-pyrrol-3-yl]-8,15-dimethyl-2-methylidene-12-oxo-4,11-dioxatetracyclo[8.5.0.0³,⁵.0³,⁸]pentadec-13-en-9-yl acetate

C31H39N3O9 (597.2686)


   

3-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-3-{[1-({1-[(1-carboxyethyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)-2-phenylethyl]-c-hydroxycarbonimidoyl}propanoic acid

3-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-3-{[1-({1-[(1-carboxyethyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)-2-phenylethyl]-c-hydroxycarbonimidoyl}propanoic acid

C30H39N5O8 (597.2798)


   

15-(2,2-dimethyl-5-oxooxolan-3-yl)-7-[1-(3-hydrazinylpropanoyl)-2-oxo-5h-pyrrol-3-yl]-8,15-dimethyl-2-methylidene-12-oxo-4,11-dioxatetracyclo[8.5.0.0³,⁵.0³,⁸]pentadec-13-en-9-yl acetate

15-(2,2-dimethyl-5-oxooxolan-3-yl)-7-[1-(3-hydrazinylpropanoyl)-2-oxo-5h-pyrrol-3-yl]-8,15-dimethyl-2-methylidene-12-oxo-4,11-dioxatetracyclo[8.5.0.0³,⁵.0³,⁸]pentadec-13-en-9-yl acetate

C31H39N3O9 (597.2686)


   

(2s)-4-amino-n-[(1r,2s,3r,4r,5s)-5-amino-4-{[(2r,3r,4r,5s,6r)-6-(aminomethyl)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]oxan-2-yl]oxy}-3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl]-2-hydroxybutanimidic acid

(2s)-4-amino-n-[(1r,2s,3r,4r,5s)-5-amino-4-{[(2r,3r,4r,5s,6r)-6-(aminomethyl)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]oxan-2-yl]oxy}-3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl]-2-hydroxybutanimidic acid

C23H43N5O13 (597.2857)


   

(3s)-3-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-{[(1s)-1-{[(1s)-1-{[(1s)-1-carboxyethyl]-c-hydroxycarbonimidoyl}-2-phenylethyl]-c-hydroxycarbonimidoyl}-2-phenylethyl]-c-hydroxycarbonimidoyl}propanoic acid

(3s)-3-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-{[(1s)-1-{[(1s)-1-{[(1s)-1-carboxyethyl]-c-hydroxycarbonimidoyl}-2-phenylethyl]-c-hydroxycarbonimidoyl}-2-phenylethyl]-c-hydroxycarbonimidoyl}propanoic acid

C30H39N5O8 (597.2798)


   

4-amino-n-(5-amino-4-{[6-(aminomethyl)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]oxan-2-yl]oxy}-3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl)-2-hydroxybutanimidic acid

4-amino-n-(5-amino-4-{[6-(aminomethyl)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]oxan-2-yl]oxy}-3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl)-2-hydroxybutanimidic acid

C23H43N5O13 (597.2857)